Synthesis of a water soluble boron neutron capture therapy agent:: 1-amino-3-[2-(7-{3-[2-(2-hydroxymethyl-ethoxy)-1-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)ethoxy]propyl}-1,7-di-carba-closo-dodecaboran-1-yl)ethyl]cyclobutanecarboxylic acid

被引:27
作者
Das, BC
Kabalka, GW [1 ]
Srivastava, RR
Bao, WL
Das, S
Li, GS
机构
[1] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA
[2] Univ Tennessee, Dept Radiol, Knoxville, TN 37996 USA
关键词
BNCT; polyol; amino acid; carborane;
D O I
10.1016/S0022-328X(00)00630-6
中图分类号
O61 [无机化学];
学科分类号
070301 ; 081704 ;
摘要
A water soluble boronated amino acid containing a cascade polyol, 1-amino-3-[2-(7-{3-[2-(2-hydroxymethyl-ethoxy)-1-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)ethoxy]propyl}-1,7-di-carba-closo-dodecarboran-1-yl)ethyl]cyclobutanecarboxylic acid,has been developed. The key step in the synthesis is the alkylation of 3-[2-(1,7-dicarba-closo-docfecarboran-1-yl)ethyl]cyclobutanone hemithioketal with toluene-4-sulfonic acid 3-[2-(2-benzyloxy-1-benzyloxymethyl-ethoxy)-1-(2-benzyloxy-1-benzyloxymethyl-ethoxymethyl)ethoxy]propyl ester which gave the required precursor ketone which was then converted to the title amino acid via a Bucherer-Strecker synthesis followed by hydrogenolysis to remove the benzyl protecting groups. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:255 / 261
页数:7
相关论文
共 36 条
[1]   SYNTHESIS OF A CARBORANYL NUCLEOSIDE FOR POTENTIAL USE IN NEUTRON-CAPTURE THERAPY OF CANCER [J].
ANISUZZAMAN, AKM ;
ALAM, F ;
SOLOWAY, AH .
POLYHEDRON, 1990, 9 (06) :891-892
[2]  
ASBURY A K, 1972, Journal of Neuropathology and Experimental Neurology, V31, P278, DOI 10.1097/00005072-197204000-00005
[3]   Boron neutron capture therapy of brain tumors: An emerging therapeutic modality [J].
Barth, RF ;
Soloway, AH ;
Goodman, JH ;
Gahbauer, RA ;
Gupta, N ;
Blue, TE ;
Yang, WL ;
Tjarks, W .
NEUROSURGERY, 1999, 44 (03) :433-450
[4]   SYNTHESIS AND CHARACTERIZATION OF OLIGOMERIC NIDO-CARBORANYL PHOSPHATE DIESTER CONJUGATES TO ANTIBODY AND ANTIBODY FRAGMENTS FOR POTENTIAL USE IN BORON NEUTRON-CAPTURE THERAPY OF SOLID TUMORS [J].
CHEN, CJ ;
KANE, RR ;
PRIMUS, FJ ;
SZALAI, G ;
HAWTHORNE, MF ;
SHIVELY, JE .
BIOCONJUGATE CHEMISTRY, 1994, 5 (06) :557-564
[5]   SELECTIVE ABLATION OF RAT-BRAIN TUMORS BY BORON NEUTRON-CAPTURE THERAPY [J].
CODERRE, J ;
RUBIN, P ;
FREEDMAN, A ;
HANSEN, J ;
WOODING, TS ;
JOEL, D ;
GASH, D .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (05) :1067-1077
[6]   CURRENT STATUS OF B-10-NEUTRON CAPTURE THERAPY - ENHANCEMENT OF TUMOR DOSE VIA BEAM FILTRATION AND DOSE-RATE, AND THE EFFECTS OF THESE PARAMETERS ON MINIMUM BORON CONTENT - A THEORETICAL EVALUATION [J].
FAIRCHILD, RG ;
BOND, VP .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (04) :831-840
[7]  
FAUCHERE JL, 1979, HELV CHIM ACTA, V62, P1382
[8]   BORON-CONTAINING PYRIMIDINES, NUCLEOSIDES, AND OLIGONUCLEOTIDES FOR NEUTRON-CAPTURE THERAPY [J].
GOUDGAON, NM ;
ELKATTAN, GF ;
SCHINAZI, RF .
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 1994, 13 (1-3) :849-880
[9]   CLINICAL PHASE-I STUDY OF NA2B12H11SH (BSH) IN PATIENTS WITH MALIGNANT GLIOMA AS PRECONDITION FOR BORON NEUTRON-CAPTURE THERAPY (BNCT) [J].
HARITZ, D ;
GABEL, D ;
HUISKAMP, R .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (05) :1175-1181
[10]   CLINICAL-RESULTS OF LONG-SURVIVING BRAIN-TUMOR PATIENTS WHO UNDERWENT BORON NEUTRON-CAPTURE THERAPY [J].
HATANAKA, H ;
NAKAGAWA, Y .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (05) :1061-1066